Literature DB >> 11998705

Emerging Chagas disease in Amazonian Brazil.

José Rodrigues Coura1, Angela C V Junqueira, Octavio Fernandes, Sebastiao A S Valente, Michael A Miles.   

Abstract

In the Amazon Basin, Trypanosoma cruzi infection is enzootic, involving a variety of wild mammals and at least 10 of the 16 reported silvatic triatomine bug species. Human cases of Chagas disease are increasing, indicating that the disease may be emerging as a wider public health problem in the region: 38 cases from 1969 to 1992, and 167 in the past eight years. This article reviews the status of Chagas disease in Amazonian Brazil, including known reservoirs and vectors, and the genetic diversity of T. cruzi. At least three subspecific groups of T. cruzi-T. cruzilZ1, T. cruziZ3 and T. cruziZ3/Z1 ASAT--are present. It appears that T. cruzil has an extant capacity for genetic exchange. Attention is also drawn to the risk of domestic endemicity, in addition to the tasks facing the disease control authorities.

Entities:  

Mesh：

Year:  2002        PMID： 11998705     DOI： 10.1016/s1471-4922(01)02200-0

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


  63 in total

Review 1.  American trypanosomiasis (Chagas' disease) and the role of molecular epidemiology in guiding control strategies.

Authors:  Michael A Miles; M Dora Feliciangeli; Antonieta Rojas de Arias
Journal:  BMJ       Date:  2003-06-28

2.  Trypanosoma cruzi: experimental parasitism of bone and cartilage.

Authors:  Antonio Morocoima; Marlene Rodríguez; Leidi Herrera; Servio Urdaneta-Morales
Journal:  Parasitol Res       Date:  2006-05-24       Impact factor: 2.289

Review 3.  The elimination of Chagas' disease from Brazil.

Authors:  E Massad
Journal:  Epidemiol Infect       Date:  2007-12-04       Impact factor: 2.451

4.  Sustainability of vector control strategies in the Gran Chaco Region: current challenges and possible approaches.

Authors:  Ricardo E Gürtler
Journal:  Mem Inst Oswaldo Cruz       Date:  2009-07       Impact factor: 2.743

5.  Tc52 amino-terminal-domain DNA carried by attenuated Salmonella enterica serovar Typhimurium induces protection against a Trypanosoma cruzi lethal challenge.

Authors:  Marina N Matos; Silvia I Cazorla; Augusto E Bivona; Celina Morales; Carlos A Guzmán; Emilio L Malchiodi
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

6.  Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease.

Authors:  Claudia R De Marchi; Javier M Di Noia; Alberto C C Frasch; Vicente Amato Neto; Igor C Almeida; Carlos A Buscaglia
Journal:  Clin Vaccine Immunol       Date:  2011-08-31

7.  Modeling disease vector occurrence when detection is imperfect: infestation of Amazonian palm trees by triatomine bugs at three spatial scales.

Authors:  Fernando Abad-Franch; Gonçalo Ferraz; Ciro Campos; Francisco S Palomeque; Mario J Grijalva; H Marcelo Aguilar; Michael A Miles
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

8.  Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi.

Authors:  Daniela I Staquicini; Rafael M Martins; Silene Macedo; Gisela R S Sasso; Vanessa D Atayde; Maria A Juliano; Nobuko Yoshida
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

Review 9.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

10.  Genome-scale multilocus microsatellite typing of Trypanosoma cruzi discrete typing unit I reveals phylogeographic structure and specific genotypes linked to human infection.

Authors:  Martin S Llewellyn; Michael A Miles; Hernan J Carrasco; Michael D Lewis; Matthew Yeo; Jorge Vargas; Faustino Torrico; Patricio Diosque; Vera Valente; Sebastiao A Valente; Michael W Gaunt
Journal:  PLoS Pathog       Date:  2009-05-01       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.